Evolve BioSystems
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$9.0m | Series A | ||
$20.0m | Series B | ||
$40.0m | Series C | ||
$55.0m | Series D | ||
$10.0m Valuation: $275m | Series D | ||
Total Funding | $134m |
Recent News about Evolve BioSystems
EditEvolve BioSystems is a health-focused startup that operates in the infant nutrition market. The company specializes in developing products that enhance the gut microbiome of infants, thereby laying a strong foundation for their overall health. Their primary offering is a probiotic powder product called Evivo, which is designed to be mixed with breast milk. This product is based on the company's proprietary research and discovery of a bacterial strain known as B. infantis EVC001, which is believed to be crucial for infant health.
Evolve BioSystems serves a broad range of clients, including parents, healthcare providers, and partners who are interested in promoting infant health. The company's business model revolves around the sale of its Evivo product, which is certified by Nutrasource's IPRO, a leading certification body in the health and nutrition industry. This certification adds credibility to the product and increases customer trust.
The company's revenue generation strategy is based on the direct sale of its Evivo product. Customers can learn more about the product and make purchases through the company's website or by contacting their customer service. The company also provides support to its customers, ensuring they understand how to use the product effectively.
In summary, Evolve BioSystems is a health and nutrition startup that leverages scientific research to develop products that enhance infant health by improving gut microbiome.
Keywords: Infant Nutrition, Gut Microbiome, Probiotic Powder, Evivo, B. infantis EVC001, Health Startup, Nutrasource's IPRO Certification, Direct Sales, Customer Support, Scientific Research.